190 related articles for article (PubMed ID: 20956006)
1. Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates.
Yoo MJ; Hage DS
J Chromatogr A; 2011 Apr; 1218(15):2072-8. PubMed ID: 20956006
[TBL] [Abstract][Full Text] [Related]
2. High-throughput analysis of drug dissociation from serum proteins using affinity silica monoliths.
Yoo MJ; Hage DS
J Sep Sci; 2011 Aug; 34(16-17):2255-63. PubMed ID: 21661111
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug-protein binding.
Yoo MJ; Schiel JE; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1707-13. PubMed ID: 20462808
[TBL] [Abstract][Full Text] [Related]
4. Kinetic studies of drug-protein interactions by using peak profiling and high-performance affinity chromatography: examination of multi-site interactions of drugs with human serum albumin columns.
Tong Z; Schiel JE; Papastavros E; Ohnmacht CM; Smith QR; Hage DS
J Chromatogr A; 2011 Apr; 1218(15):2065-71. PubMed ID: 21067755
[TBL] [Abstract][Full Text] [Related]
5. Determination of rate constants and equilibrium constants for solution-phase drug-protein interactions by ultrafast affinity extraction.
Zheng X; Li Z; Podariu MI; Hage DS
Anal Chem; 2014 Jul; 86(13):6454-60. PubMed ID: 24911267
[TBL] [Abstract][Full Text] [Related]
6. Analysis of drug-protein binding by ultrafast affinity chromatography using immobilized human serum albumin.
Mallik R; Yoo MJ; Briscoe CJ; Hage DS
J Chromatogr A; 2010 Apr; 1217(17):2796-803. PubMed ID: 20227701
[TBL] [Abstract][Full Text] [Related]
7. Optimization of protein entrapment in affinity microcolumns using hydrazide-activated silica and glycogen as a capping agent.
Vargas-Badilla J; Poddar S; Azaria S; Zhang C; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jul; 1121():1-8. PubMed ID: 31079009
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of silica monoliths in affinity microcolumns for high-throughput analysis of drug-protein interactions.
Yoo MJ; Hage DS
J Sep Sci; 2009 Aug; 32(15-16):2776-85. PubMed ID: 19630007
[TBL] [Abstract][Full Text] [Related]
9. Analysis of drug-protein binding using on-line immunoextraction and high-performance affinity microcolumns: Studies with normal and glycated human serum albumin.
Matsuda R; Jobe D; Beyersdorf J; Hage DS
J Chromatogr A; 2015 Oct; 1416():112-20. PubMed ID: 26381571
[TBL] [Abstract][Full Text] [Related]
10. Noncompetitive peak decay analysis of drug-protein dissociation by high-performance affinity chromatography.
Chen J; Schiel JE; Hage DS
J Sep Sci; 2009 May; 32(10):1632-41. PubMed ID: 19472288
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography.
Joseph KS; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1590-8. PubMed ID: 20435530
[TBL] [Abstract][Full Text] [Related]
12. Development of an affinity silica monolith containing human serum albumin for chiral separations.
Mallik R; Hage DS
J Pharm Biomed Anal; 2008 Apr; 46(5):820-30. PubMed ID: 17475436
[TBL] [Abstract][Full Text] [Related]
13. Analysis of free drug fractions in serum by ultrafast affinity extraction and two-dimensional affinity chromatography using α1-acid glycoprotein microcolumns.
Bi C; Zheng X; Hage DS
J Chromatogr A; 2016 Feb; 1432():49-57. PubMed ID: 26797422
[TBL] [Abstract][Full Text] [Related]
14. Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC).
Kim HS; Wainer IW
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(1):22-6. PubMed ID: 18554995
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of microcolumn stability in ultrafast affinity extraction for binding and rate studies.
Iftekhar S; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Dec; 1187():123047. PubMed ID: 34823097
[TBL] [Abstract][Full Text] [Related]
16. Optimization of human serum albumin monoliths for chiral separations and high-performance affinity chromatography.
Pfaunmiller EL; Hartmann M; Dupper CM; Soman S; Hage DS
J Chromatogr A; 2012 Dec; 1269():198-207. PubMed ID: 23010249
[TBL] [Abstract][Full Text] [Related]
17. Characterization of interaction kinetics between chiral solutes and human serum albumin by using high-performance affinity chromatography and peak profiling.
Tong Z; Hage DS
J Chromatogr A; 2011 Sep; 1218(39):6892-7. PubMed ID: 21872871
[TBL] [Abstract][Full Text] [Related]
18. Chromatographic studies of chlorpropamide interactions with normal and glycated human serum albumin based on affinity microcolumns.
Tao P; Li Z; Matsuda R; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1097-1098():64-73. PubMed ID: 30205233
[TBL] [Abstract][Full Text] [Related]
19. Development of an on-line immunoextraction/entrapment system for protein capture and use in drug binding studies by high-performance affinity chromatography.
Rodriguez EL; Poddar S; Choksi M; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jan; 1136():121812. PubMed ID: 31841979
[TBL] [Abstract][Full Text] [Related]
20. High-performance affinity monolith chromatography: development and evaluation of human serum albumin columns.
Mallik R; Jiang T; Hage DS
Anal Chem; 2004 Dec; 76(23):7013-22. PubMed ID: 15571354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
